Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.7.0.1
Stockholders' Equity (Details Narrative) - USD ($)
 3 Months Ended
Feb. 28, 2017
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Number of shares issued during period, value   $ 40,500    
Shares issued, price per share       $ 2.50
Other comprehensive income (loss)   $ 200,259 $ (405,723)  
Warrants term   5 years 5 years  
Warrant to purchase common stock   2,250 98,378  
Warrants exercise price   $ 2.00 $ 2.50  
Share based compensation   $ 1,105 $ 84,105  
Weighted average grant fair value price per share   $ 0.52 $ 1.03  
Stock option annual rate   5.00%    
Series A Convertible Preferred Stock [Member]        
Preferred stock, shares designated       10,097,330
Preferred stock, par or stated value per share   $ 0.01   $ 0.01
Debt instrument interest rate       8.00%
Fair value of common stock, votes       $ 10
Series B Convertible Preferred Stock [Member]        
Preferred stock, shares designated 902,670      
Series B Preferred Stock [Member]        
Cumulative dividends   $ 3,053    
Shares converted into stock 10      
Number of shares issued during period   28,500    
Number of shares issued during period, value   $ 285,000    
Shares issued, price per share   $ 10.00    
Debt converted into shares   126,700    
Common Stock [Member]        
Number of shares issued during period   22,500    
Number of shares issued during period, value   $ 45,000    
Shares issued, price per share   $ 2.00    
Debt converted into shares   4,500    
Stock Option [Member]        
Share based compensation   $ 163,424 $ 149,987  
Unrecognized stock-based compensation expense related to stock option grants   $ 1,424,705    
Weighted average period   2 years    
Unrecognized expense to non-employee   $ 380,667